BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 19124066)

  • 1. Modeling a system of phosphated cross-linked high amylose for controlled drug release. Part 2: physical parameters, cross-linking degrees and drug delivery relationships.
    Cury BS; Castro AD; Klein SI; Evangelista RC
    Int J Pharm; 2009 Apr; 371(1-2):8-15. PubMed ID: 19124066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
    Shaheen SM; Takezoe K; Yamaura K
    Biomed Mater Eng; 2004; 14(4):371-82. PubMed ID: 15472386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ionotropic cross-linked chitosan microspheres for controlled release of ampicillin.
    Anal AK; Stevens WF; Remuñán-López C
    Int J Pharm; 2006 Apr; 312(1-2):166-73. PubMed ID: 16497452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physical properties of pectin-high amylose starch mixtures cross-linked with sodium trimetaphosphate.
    Carbinatto FM; de Castro AD; Cury BS; Magalhães A; Evangelista RC
    Int J Pharm; 2012 Feb; 423(2):281-8. PubMed ID: 22178896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutaraldehyde and glyoxal cross-linked chitosan microspheres for controlled delivery of centchroman.
    Gupta KC; Jabrail FH
    Carbohydr Res; 2006 May; 341(6):744-56. PubMed ID: 16499893
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cross-linked high amylose starch derivatives for drug release. II. Swelling properties and mechanistic study.
    Mulhbacher J; Ispas-Szabo P; Mateescu MA
    Int J Pharm; 2004 Jul; 278(2):231-8. PubMed ID: 15196628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Membrane formation and drug loading effects in high amylose starch tablets studied by NMR imaging.
    Thérien-Aubin H; Zhu XX; Ravenelle F; Marchessault RH
    Biomacromolecules; 2008 Apr; 9(4):1248-54. PubMed ID: 18357992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
    Wang GM; Chen CH; Ho HO; Wang SS; Sheu MT
    Int J Pharm; 2006 Aug; 319(1-2):71-81. PubMed ID: 16701971
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preparation and characterization of free films of high amylose/pectin mixtures cross-linked with sodium trimetaphosphate.
    Prezotti FG; Meneguin AB; Evangelista RC; Cury BS
    Drug Dev Ind Pharm; 2012 Nov; 38(11):1354-9. PubMed ID: 22251099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carboxymethyl high amylose starch as excipient for controlled drug release: mechanistic study and the influence of degree of substitution.
    Lemieux M; Gosselin P; Mateescu MA
    Int J Pharm; 2009 Dec; 382(1-2):172-82. PubMed ID: 19716866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mucoadhesive properties of cross-linked high amylose starch derivatives.
    Mulhbacher J; Ispas-Szabo P; Ouellet M; Alex S; Mateescu MA
    Int J Biol Macromol; 2006 Dec; 40(1):9-14. PubMed ID: 16837041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of drying technique on some physical properties of cross-linked high amylose/pectin mixtures.
    Soares GA; Carbinatto FM; Cury BS; Evangelista RC
    Drug Dev Ind Pharm; 2013 Feb; 39(2):284-9. PubMed ID: 22519692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and characterization of oxidized starch polymer microgels for encapsulation and controlled release of functional ingredients.
    Li Y; de Vries R; Slaghek T; Timmermans J; Cohen Stuart MA; Norde W
    Biomacromolecules; 2009 Jul; 10(7):1931-8. PubMed ID: 19453163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of hydration of cross-linked high amylose starch by solid state 13C NMR spectroscopy.
    Thérien-Aubin H; Janvier F; Baille WE; Zhu XX; Marchessault RH
    Carbohydr Res; 2007 Aug; 342(11):1525-9. PubMed ID: 17509547
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of crosslinked chitosan hydrogel beads as a carrier for prolonged delivery of diclofenac sodium: in vitro and in vivo studies.
    Alsarra IA
    Boll Chim Farm; 2004 Dec; 143(10):359-64. PubMed ID: 15881815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Temperature-sensitive chitosan-poly(N-isopropylacrylamide) interpenetrated networks with enhanced loading capacity and controlled release properties.
    Alvarez-Lorenzo C; Concheiro A; Dubovik AS; Grinberg NV; Burova TV; Grinberg VY
    J Control Release; 2005 Feb; 102(3):629-41. PubMed ID: 15681085
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of sodium hexameta phosphate cross-linked chitosan microspheres for controlled and sustained delivery of centchroman.
    Gupta KC; Jabrail FH
    Int J Biol Macromol; 2006 May; 38(3-5):272-83. PubMed ID: 16620951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained release of 5-FU from Poloxamer gels interpenetrated by crosslinking chitosan network.
    Chung TW; Lin SY; Liu DZ; Tyan YC; Yang JS
    Int J Pharm; 2009 Dec; 382(1-2):39-44. PubMed ID: 19666095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled release study of 5-fluorouracil-loaded chitosan/polyethylene glycol microparticles.
    Lin CC; Fu CH
    Drug Deliv; 2009 Jul; 16(5):274-9. PubMed ID: 19538009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hydroxypropylated starches of varying amylose contents as sustained release matrices in tablets.
    Onofre FO; Wang YJ
    Int J Pharm; 2010 Jan; 385(1-2):104-12. PubMed ID: 19879935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.